HCS Pharma is a biotechnology company focused on in vitro R&D. HCS Pharma manufactures and sells products based on BIOMIMESYS® technology, and develops its own 3D cellular models in its proprietary BIOMIMESYS® Hydroscaffold™. BIOMIMESYS® 3D culture technology faithfully reproduces the natural 3D cells microenvironment , including matrix architecture, cellular organization, biological cell-cell and biomechanical cell-matrix interactions with fully natural compounds.
BIOMIMESYS® matrices are made of Hyaluronic Acid (HA), the main glycosaminoglycan (GAG) of the ECM, collagens and adhesion proteins. Our patented manufacturing process complies with the green chemistry convention allow preserving the natural properties of HA and therefore synthesizing proprietary Hydroscaffold™. Depending on the tissue needed extracellular matrix components may change as well their proportions, allowing a soft or a stiff cellular environment.
The exclusive BIOMIMESYS® technology from HCS Pharma is used in the Eurostar ScaLABle-MEAT project to invent the next generation of food - sustainable, safe and respectful to animals.